A recent GWAS demonstrated that the genetic diversity of HLA-DRB1 and HLA-DQB1 alleles modulates responses to treatment with lithium-containing drugs in bipolar affective disorders [80]. The gene discussed is HLA-DRB1; the disease is bipolar disorder.